Table 3 Comparison of characteristics between TAE and non-TAE groups
Variable | TAE (n=5) (%) | non-TAE (n=46) (%) | p value | |
|---|---|---|---|---|
Patient factors | ||||
Age | 65 [63–78] | 71 [16–85] | 0.526 | |
Sex | Male | 5 (100.0) | 37 (80.4) | 0.571 |
Etiology | NBNC | 3 (60.0) | 22 (47.8) | 0.999 |
ICG-R15 (%) | 15.4 [7.5–24.8] | 13.2 [2.7–75.6] | 0.727 | |
Child-Pugh | B | 0 (0.0) | 2 (4.5) | 0.999 |
Tumor factors | ||||
AFP (ng/ml) | 7.2 [2.2–79.6] | 14.8 [0.8–128900] | 0.265 | |
AFP-L3 (%) | 0.0 [0.0–11.4] | 9.9 [0.0–84.0] | 0.150 | |
PIVKA-II (mAU/ml) | 125.0 [14.0–68901.0] | 1056.0 [12.0–96988.0] | 0.974 | |
Tumor size (mm) | 100 [55–130] | 65 [50–140] | 0.050 | |
Tumor number | Multiple | 3 (60.0) | 12 (26.1) | 0.144 |
Tumor location | Right lobe | 5 (100.0) | 26 (56.5) | 0.143 |
Perioperative factors | ||||
PVE | Present | 2 (40.0) | 7 (15.2) | 0.209 |
IBL (mL) | 2017 [828–2087] | 717 [122–3330] | 0.011 | |
Operation time (min) | 690 [629–791] | 453 [257–694] | 0.001 | |
Blood transfusion | Present | 4 (80.0) | 9 (19.6) | 0.012 |
Residual tumor | R1/2 | 0 (0.0) | 5 (10.9) | 0.999 |
Postoperative complications | CD ≥2 | 3 (60.0) | 13 (28.3) | 0.309 |